Business
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board.
About this update from Avenir Wellness Solutions Inc.
[{"type":"text","content":"\n\n OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today the appointment of CannaKids Founder and CEO Tracy Ryan to its advisory board.\n Ryan founded CannaKids, a California Cooperative Cooperation that specializes in the creation of lab tested and Ph.D. scientist extracted cannabis oils, after realizing success using cannabinoid therapy on her own 8 ½-month-old infant who was diagnosed with a rare brain tumor. After establishing CannaKids in mid-2014, Ryan partnered with scientists and pediatric physicians to formulate her own cannabinoid product line that was later released into the California market in 2015. CURE and CannaKids first collaborated in March 2017 to develop and research the delivery of various cannabinoid molecules for both human and animal pharmaceutical use via CURE’s patented drug delivery technology. “We are excited to have Tracy join our Advisory Board and look forward to utilizing the experience she has gained educating the mass public on the power of the cannabis plant, as we continue our work in the pharmaceutical cannabis sector,” said CEO of CURE Rob Davidson. “Tracy has vast, first-hand knowledge on the medicinal powers of cannabis in treating her own daughter’s disease and has worked on a global scale helping families who seek education and treatment options, guiding many patients to a better quality of life.” “I am looking forward to developing an even more intimate partnership with the CURE team as a member of the Company’s Advisory Board,” said CannaKids CEO and Founder Tracy Ryan. “We are in a brave new world of plant-based cannabinoid molecules, and it is an honor to be lending my own experience to the brilliant minds at CURE, as they work to usher in a new line of cannabinoid therapies to the pharmaceutical marketplace.” Tracy is also the CEO of CK Sciences, and the founder of a 501c3 non-profit, SavingSophie.org, which focuses on cancer, epilepsy and autism education as well as raising funds for patients in need. Ryan is a global speaker and can be found on stages around the world educating and advocating for medical cannabis patients of all ages. In...